{"id":"https://openalex.org/W4400523312","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.605","title":"Automated prediction of response to neoadjuvant chemotherapy from digitized H&E slides of pre-treatment core needle biopsies in germline BRCA carriers with HER2-negative breast cancer (TBCRC 031).","display_name":"Automated prediction of response to neoadjuvant chemotherapy from digitized H&E slides of pre-treatment core needle biopsies in germline BRCA carriers with HER2-negative breast cancer (TBCRC 031).","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4400523312","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.605"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.605","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.605","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.605","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051532432","display_name":"Nadine Tung","orcid":"https://orcid.org/0000-0003-1422-3734","observed_orcids":["https://orcid.org/0000-0003-1422-3734"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadine M. Tung","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007365512","display_name":"Stuart J. Schnitt","orcid":"https://orcid.org/0000-0002-3608-7828","observed_orcids":["https://orcid.org/0000-0002-3608-7828"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart J. Schnitt","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005206482","display_name":"Judy Ellen Garber","orcid":"https://orcid.org/0000-0001-9449-3982","observed_orcids":["https://orcid.org/0000-0001-9449-3982"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judy Ellen Garber","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022000019","display_name":"Satabhisa Mukhopadhyay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Satabhisa Mukhopadhyay","raw_affiliation_strings":["4D Path Inc., Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4D Path Inc., Newton, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025897258","display_name":"Tathagata Dasgupta","orcid":"https://orcid.org/0000-0003-3921-0649","observed_orcids":["https://orcid.org/0000-0003-3921-0649"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tathagata Dasgupta","raw_affiliation_strings":["4D Path Inc., Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4D Path Inc., Newton, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109935420","display_name":"Craig A. Bunnell","orcid":"https://orcid.org/0000-0001-9063-3124","observed_orcids":["https://orcid.org/0000-0001-9063-3124"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig A. Bunnell","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"605","last_page":"605"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10862","display_name":"AI in cancer detection","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1702","display_name":"Artificial Intelligence"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10862","display_name":"AI in cancer detection","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1702","display_name":"Artificial Intelligence"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.01889999955892563,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy-response-prediction","display_name":"neoadjuvant chemotherapy response prediction","score":0.8989999890327454},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/core-needle-biopsy","display_name":"core needle biopsy","score":0.746999979019165},{"id":"https://openalex.org/keywords/digital-biomarkers","display_name":"digital biomarkers","score":0.8100000023841858},{"id":"https://openalex.org/keywords/tumor-immune-heterogeneity","display_name":"tumor immune heterogeneity","score":0.6899999976158142},{"id":"https://openalex.org/keywords/stromal-tumor-infiltrating-lymphocytes","display_name":"stromal tumor-infiltrating lymphocytes","score":0.9070000052452087},{"id":"https://openalex.org/keywords/cell-cycle-dysregulation","display_name":"cell cycle dysregulation","score":0.8059999942779541},{"id":"https://openalex.org/keywords/ki-67-proliferation-index","display_name":"Ki-67 proliferation index","score":0.5149999856948853},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.5099999904632568},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.9010000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9122567176818848},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6535085439682007},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6076690554618835},{"id":"https://openalex.org/C3019914693","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Core biopsy","level":4,"score":0.5739967226982117},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5703011751174927},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5516246557235718},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.5051820874214172},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49208372831344604},{"id":"https://openalex.org/C2910363380","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"HER2 negative","level":5,"score":0.4506835341453552},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.27049019932746887},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.605","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.605","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.605","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410809742","https://openalex.org/W4399123757","https://openalex.org/W4306915005","https://openalex.org/W4308844538","https://openalex.org/W3085288244","https://openalex.org/W4281654670","https://openalex.org/W4284967795","https://openalex.org/W4385644766","https://openalex.org/W4409127671","https://openalex.org/W3047999461"],"abstract_inverted_index":{"605":[0],"Background:":[1],"The":[2,34,216],"INFORM":[3],"trial,":[4],"a":[5,74,86,102,304,308],"phase":[6,310],"II":[7],"study":[8,39],"of":[9,36,45,63,226,234,316,324,326,413],"neoadjuvant":[10,78],"cisplatin":[11],"(C)":[12],"vs":[13],"doxorubicin-cyclophosphamide":[14],"(AC)":[15],"in":[16,27,270,277,409,416],"germline":[17,417],"BRCA":[18,418],"carriers":[19,419],"with":[20,73,85,94,211,237,241,247,250,296,303,319,420],"HER2-negative":[21,421],"breast":[22,422],"cancer,":[23],"demonstrated":[24],"no":[25],"difference":[26],"response":[28,76,88,415],"rates":[29],"between":[30],"the":[31,37,49,109,278],"two":[32],"arms.":[33],"aim":[35],"current":[38],"was":[40,198,232,314],"to":[41,48,77,113,151,169,176,185,205],"determine":[42,170,206],"if":[43,171,207],"quantification":[44],"features":[46,150,328],"related":[47],"immune":[50],"response,":[51],"proliferative":[52,305],"status,":[53],"and":[54,123,147,162,191,202,282,293,307,368,375,386,399,406],"key":[55,124,400],"cell":[56,125,153,401],"cycle":[57,126,154,402],"deregulation":[58,127,311],"extracted":[59],"from":[60,83,156],"digital":[61,115],"images":[62,160],"H&E-stained":[64],"pre-treatment":[65],"core":[66],"needle":[67],"biopsies":[68],"(CNB)":[69],"could":[70,131,173],"distinguish":[71],"patients":[72,246],"good":[75],"chemotherapy":[79],"(NAC)":[80],"(RCB":[81,89],"0,1)":[82],"those":[84],"poor":[87],"2,3).":[90],"Methods:":[91],"CNBs":[92],"(n=92":[93],"RCB":[95,235,248,272,317,363],"scores":[96],"available)":[97],"scanned":[98],"at":[99,165],"40x":[100],"on":[101,140,200],"Hamamatsu":[103],"Nanozoomer":[104],"scanner":[105],"were":[106,138,163,181,209],"evaluated":[107,164],"using":[108,183],"4D":[110],"QPOR":[111,179,217],"platform":[112],"generate":[114],"biomarkers":[116,136],"as":[117],"continuous":[118],"indices":[119,180,404],"measuring":[120,222],"immune,":[121,397],"proliferation,":[122],"signatures.":[128],"96%":[129],"(88/92)":[130],"be":[132],"analyzed":[133,182],"successfully.":[134],"All":[135],"generated":[137],"based":[139],"an":[141],"algorithm":[142],"that":[143,323],"combines":[144],"statistical":[145],"physics":[146],"tumor":[148,228],"biology":[149],"quantify":[152],"aberrations,":[155],"H&E":[157],"whole":[158],"slide":[159],"alone,":[161],"their":[166],"median":[167],"cut-off":[168],"they":[172,208],"identify":[174],"responders":[175],"NAC.":[177],"Other":[178],"AUC-ROC":[184],"further":[186],"reduce":[187],"false":[188,192],"positive":[189],"(FP)":[190],"negative":[193],"(FN)":[194],"rates.":[195],"Pathology":[196],"review":[197],"done":[199],"FP":[201],"FN":[203],"cases":[204],"associated":[210,240],"any":[212,325],"specific":[213],"features.":[214],"Results:":[215],"Immune":[218],"Heterogeneity":[219],"Index":[220],"(IHI),":[221],"intra-slide":[223],"spatial":[224],"heterogeneity":[225,239],"stromal":[227],"infiltrating":[229],"lymphocytes":[230],"(sTIL),":[231],"predictive":[233,315,412],"0,1":[236,249,273,318,364],"greater":[238],"worse":[242],"response.":[243],"IHI":[244,267,301,393],"identified":[245],"overall":[251],"accuracy":[252,321,331],"=":[253,256,259,262,265,290,332,335,338,341,344,347,353,381],"65%,":[254],"sensitivity":[255,334],"63%,":[257],"specificity":[258,337],"66%,":[260],"PPV":[261,340],"62%,":[263],"NPV":[264,343],"67%.":[266],"performed":[268],"better":[269,361],"predicting":[271],"than":[274,392],"pathologist-identified":[275],"sTIL":[276],"full":[279],"cohort,":[280],"TNBC,":[281],"BRCA1":[283],"sub-cohorts":[284],"(two":[285],"sample":[286],"Wilcoxon":[287],"test":[288],"p-value":[289],"0.013,":[291],"0.047":[292],"0.013":[294],"respectively,":[295],"nonsignificant":[297],"p-values":[298],"for":[299,365],"sTIL).":[300],"combined":[302],"index":[306,312],"G1S":[309],"(CmbI)":[313],"improved":[320],"over":[322],"these":[327],"alone":[329],"(overall":[330],"80%,":[333],"71%,":[336],"87%,":[339],"83%,":[342],"77%,":[345],"OR":[346,380],"16.51":[348],"95%":[349,357,372,377,383,388],"CI:":[350,358,373,378,384,389],"10.05-1.14,":[351],"kappa":[352],"0.59":[354],"(p<0.00001),":[355],"AUC=0.80":[356],"0.71-0.89).":[359],"CmbI":[360],"predicted":[362],"both":[366],"AC":[367],"C":[369],"arms":[370],"(AUC=0.83":[371],"0.71-0.96":[374],"0.77":[376],"0.63-0.91,":[379],"23.22":[382],"148.88-5.10":[385],"6.47":[387],"28.08-1.72,":[390],"respectively)":[391],"alone.":[394],"Conclusions:":[395],"QPOR-generated":[396],"proliferative,":[398],"signature":[403],"individually,":[405],"more":[407],"strongly":[408],"combination,":[410],"appear":[411],"NAC":[414],"cancers.":[423]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2024-07-12T00:00:00"}